HCG
IDXX icon

Haven Capital Group’s Idexx Laboratories IDXX Stock Holding History

Haven Capital Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.05M Sell
11,492
-645
-5% -$362K 4.86% 6
2026
Q1 		$6.82M Hold
12,137
– – 6.33% 5
2025
Q4 		$8.21M Sell
12,137
-1,532
-11% -$1.04M 7.7% 4
2025
Q3 		$8.73M Sell
13,669
-423
-3% -$257K 7.78% 4
2025
Q2 		$7.56M Sell
14,092
-47
-0.3% -$22.5K 6.66% 5
2025
Q1 		$5.94M Buy
14,139
+435
+3% +$189K 6.54% 4
2024
Q4 		$5.67M Buy
+13,704
New +$6.01M 5.32% 5

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Haven Capital Group's IDXX Position: Q2 2026 in Review

Haven Capital Group reduced its Idexx Laboratories (IDXX) stake by 5.3% in Q2 2026, selling an estimated $362K and leaving 11,492 shares worth $6.05M. The position accounts for 4.86% of the portfolio, ranked #6.

Haven Capital Group first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.73M in Q3 2025. 1,293 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Haven Capital Group held 11,492 shares of Idexx Laboratories worth $6.05M as of Q2 2026.
  • Haven Capital Group sold 645 Idexx Laboratories shares in Q2 2026, an estimated $362K.
  • Idexx Laboratories made up 4.86% of Haven Capital Group's portfolio in Q2 2026, its #6 holding.
  • Haven Capital Group first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Haven Capital Group's Idexx Laboratories position peaked at $8.73M in Q3 2025.
  • 1,293 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Haven Capital Group's 13F filing for Q2 2026, filed 10 Jul 2026.